Old Web
English
Sign In
Acemap
>
authorDetail
>
Carla Boquimpani
Carla Boquimpani
Immunology
Myeloid leukemia
Medicine
Tyrosine kinase
Internal medicine
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral Asciminib (ABL001) vs Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Received ≥ 2 Prior Tyrosine Kinase Inhibitors (TKIs): A Multicenter, Open-Label, Randomized, Phase 3 Study
2017
Clinical Lymphoma, Myeloma & Leukemia
Michael J. Mauro
Carla Boquimpani
Yosuke Minami
Delphine Rea
Charisse Kemp
Shu-Fang Hsu Schmitz
Prashanth Gopalakrishna
Andreas Hochhaus
Show All
Source
Cite
Save
Citations (3)
Resource Use and Costs Associated With The Treatment Of Hematologic and NON-Hematologic Adverse Events In Chronic Myeloid Leukemia (CML) Brazilian Patients
2013
Blood
Marcia Dias Alves
Marta M. Lemos
Carla Boquimpani
Show All
Source
Cite
Save
Citations (0)
Comparasion Between Nilotinib and Dasatinib as Second-Line Therapy for Patients with Chronic Myeloid Leukemia: A Single Center Retrospective Study.
2010
Blood
Clarisse Lobo
Carla Boquimpani
Tania Silva Madeira
Patricia Wendling
Cláudia de Alvarenga Máximo
Carlos B. L. Lima
Elias H. Atta
Renata de Souza Cravo
Show All
Source
Cite
Save
Citations (0)
1